Breaking News

ACRO Appoints Global Regulatory VP

By Kristin Brooks | March 20, 2014

Noonan to build relationships with regulators and alliance partners

Karen A. Noonan has been appointed vice president of Global Regulatory Policy at the Association of Clinical Research Organizations (ACRO). Ms. Noonan most recently served as senior advisor for health policy at Onyx Pharmaceuticals. Prior to that she was director of State Government Affairs and Grassroots Advocacy at the American Society of Health System Pharmacists (ASHP).
“We welcome Karen to the ACRO team and are confident she will continue to build our relationships with regulators and alliance partners in the United States, Europe and around the globe,” said ACRO executive director Doug Peddicord, Ph.D. “We see a tremendous opportunity for CROs to take a more pro-active position in regulatory policy as our members play an increasingly important role in medical product development.”
Additionally, John Lewis will serve as senior vice president, policy and public affairs. Mr. Lewis previously served as vice president of Public Affairs with the association.
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.